Neoplasms, Ovarian Completed Phase 2 Trials for Temsirolimus (DB06287)

Also known as: Ovarian neoplasm / Ovarian Neoplasms / Neoplasms,Ovarian / Ovarian neoplasia / Ovarian tumor / Ovarian neoplasm NOS

IndicationStatusPhase
DBCOND0030336 (Neoplasms, Ovarian)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460979Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial CarcinomaTreatment